RF22c, a 5-lipoxygenase inhibitor, in monocrotaline-induced PAH

Authors :: Giuseppe Spaziano
Alejandra Catalina Muñoz Ramírez
Rosanna Filosa
Carmelo Puglia
Annalisa Capuano
Renata Esposito
Bruno D'Agostino
Angela Liparulo
Salvatore Mirra
Source :: Pulmonary hypertension.
Publication Year :: 2019
Publisher :: European Respiratory Society, 2019.

Subjects :: business.industry
5-Lipoxygenase Inhibitor
Medicine
Pharmacology
business

Tools